108010052185 Myotonin-Protein Kinase Proteins 0.000 claims description 89.125000003729 nucleotide group Chemical group 0.000 claims description 245.108020004459 Small Interfering RNA Proteins 0.000 claims description 430.206010068871 Myotonic dystrophy Diseases 0.000 title claims abstract description 13.230000020763 muscle atrophy Effects 0.000 title claims abstract description 107.201000000585 muscular atrophy Diseases 0.000 title claims abstract description 112.206010028289 Muscle atrophy Diseases 0.000 title claims abstract description 112.Assignors: AVIDITY BIOSCIENCES LLC Publication of US20190298847A1 publication Critical patent/US20190298847A1/en Publication of US10881743B2 publication Critical patent/US10881743B2/en Application granted granted Critical Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY PREVIOUSLY RECORDED AT REEL: 050018 FRAME: 0456. Assignors: AVIDITY BIOSCIENCES LLC Assigned to AVIDITY BIOSCIENCES, INC.
reassignment AVIDITY BIOSCIENCES LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: BURKE, Rob, COCHRAN, Michael Caramian, DARIMONT, Beatrice Diana, DOPPALAPUDI, VENKATA RAMANA, HOOD, Michael David, MALECOVA, Barbora, MARELIUS, GULIN ERDOGAN, SHI, Yunyu, CHU, David Sai-Ho, GEALL, ANDREW JOHN Assigned to AVIDITY BIOSCIENCES LLC, AVIDITY BIOSCIENCES, INC. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201762595545P priority Critical Priority to US201862725883P priority Priority to PCT/US2018/064359 priority patent/WO2019113393A1/en Application filed by Avidity Biosciences LLC filed Critical Avidity Biosciences LLC Priority to US16/435,422 priority patent/US10881743B2/en Assigned to AVIDITY BIOSCIENCES LLC reassignment AVIDITY BIOSCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Avidity Biosciences LLC Priority date (The priority date is an assumption and is not a legal conclusion.
Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Andrew John GEALL Venkata Ramana Doppalapudi David Sai-Ho CHU Michael Caramian COCHRAN Michael Hood Beatrice Diana DARIMONT Rob Burke Yunyu SHI Gulin Erdogan Marelius Barbora MALECOVA Current Assignee (The listed assignees may be inaccurate.
Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US16/435,422 Other versions US20190298847A1
#BECKER SATORI X 100 PDF#
Google Patents Compositions and methods of treating muscle atrophy and myotonic dystrophyĭownload PDF Info Publication number US10881743B2 US10881743B2 US16/435,422 US201916435422A US10881743B2 US 10881743 B2 US10881743 B2 US 10881743B2 US 201916435422 A US201916435422 A US 201916435422A US 10881743 B2 US10881743 B2 US 10881743B2 Authority US United States Prior art keywords instances acid molecule polynucleic acid nucleotides cases Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10881743B2 - Compositions and methods of treating muscle atrophy and myotonic dystrophy US10881743B2 - Compositions and methods of treating muscle atrophy and myotonic dystrophy
0 kommentar(er)
